Jayagopal Ashwath 4
4 · Opus Genetics, Inc. · Filed Feb 17, 2026
Research Summary
AI-generated summary of this filing
Opus Genetics CSO Jayagopal Ashwath Sells 5,313 Shares
What Happened
Jayagopal Ashwath, Chief Scientific & Development Officer of Opus Genetics (IRD), disposed of 5,313 shares on Feb 12, 2026 at $3.39 per share for a total value of about $18,011. The filing indicates these shares were withheld to satisfy tax withholding obligations arising from a restricted stock unit (RSU) vesting/settlement — an administrative disposition rather than an open-market sale.
Key Details
- Transaction date and price: Feb 12, 2026; 5,313 shares at $3.39 each (total $18,011).
- Reason/code: F — shares withheld to satisfy tax withholding on RSU vesting (footnote F1).
- This was not an open-market sale; shares were retained by the issuer to cover taxes.
- Filing date: Feb 17, 2026 (appears timely relative to the transaction date).
- Shares owned after the transaction: not specified in the provided filing.
Context
Tax-withholding dispositions following RSU vesting are routine administrative events and do not necessarily signal an insider's view of the company. For retail investors, genuine directional signals are stronger when insiders purchase shares or sell substantial holdings in open-market transactions; tax-withholding events are generally neutral informationally.
Insider Transaction Report
- Tax Payment
Common Stock
[F1]2026-02-12$3.39/sh−5,313$18,011→ 520,494 total
Footnotes (1)
- [F1]The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. Not an open market sale of securities.